Login to Your Account



FDA: No Clear Evidence Linking Bisphosphonates and Fractures

By Donna Young


Friday, March 12, 2010
WASHINGTON - After headlines emerged Wednesday about new data linking prolonged bisphosphonate use to an increased risk of atypical femur fractures, the FDA rushed to assure prescribers and the public that the agency has yet to find a clear connection. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription